CagriSema vs Tirzepatide: Head to Head Obesity Trial Results Yasir Zaroug posted on the topic LinkedIn Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Cagrilintide and semaglutide together drive record weight loss in global trial Tirzepatide, a dual GIP GLP 1 receptor co agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Cardiovascular Diabetology Springer Nature Link CagriTirz (Cagrilintide + Tirz) >99% Purity Retatrutide Legion inc